ZA826210B - Cholecalciferol derivatives - Google Patents

Cholecalciferol derivatives

Info

Publication number
ZA826210B
ZA826210B ZA826210A ZA826210A ZA826210B ZA 826210 B ZA826210 B ZA 826210B ZA 826210 A ZA826210 A ZA 826210A ZA 826210 A ZA826210 A ZA 826210A ZA 826210 B ZA826210 B ZA 826210B
Authority
ZA
South Africa
Prior art keywords
cholecalciferol
formula see
derivative
see diagramm
cholecalciferol derivatives
Prior art date
Application number
ZA826210A
Inventor
John Joseph Partridge
Jan Shiuey Shian
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA826210B publication Critical patent/ZA826210B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/34Halogenated alcohols
    • C07C31/42Polyhydroxylic acyclic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A cholecalciferol derivative of the formula see diagramm : EP0073465,P14,F3 1. Claims for the contracting state : AT A process for the manufacture of a cholecalciferol derivative of the formula see diagramm : EP0073465,P16,F1 characterized by thermally isomerizing a precholecalciferol derivative of the formula see diagramm : EP0073465,P16,F3
ZA826210A 1981-08-28 1982-08-25 Cholecalciferol derivatives ZA826210B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29744681A 1981-08-28 1981-08-28

Publications (1)

Publication Number Publication Date
ZA826210B true ZA826210B (en) 1983-07-27

Family

ID=23146345

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA826210A ZA826210B (en) 1981-08-28 1982-08-25 Cholecalciferol derivatives

Country Status (12)

Country Link
EP (1) EP0073465B1 (en)
JP (1) JPS5852268A (en)
AT (1) ATE17848T1 (en)
AU (1) AU559509B2 (en)
CA (1) CA1189537A (en)
DE (1) DE3268960D1 (en)
DK (1) DK154644C (en)
IE (1) IE53831B1 (en)
IL (1) IL66651A (en)
NZ (1) NZ201702A (en)
PH (1) PH21625A (en)
ZA (1) ZA826210B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
IE55801B1 (en) * 1982-07-26 1991-01-16 Wisconsin Alumni Res Found Novel vitamin d analogs
JPS6045516A (en) * 1983-08-02 1985-03-12 Kureha Chem Ind Co Ltd Physiologically active agent containing 1alpha- hydroxyvitamin d3
KR100756823B1 (en) * 2001-10-23 2007-09-07 주식회사 엘지생활건강 Polyethoxylated cholecalciferol derivatives and its preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51100056A (en) * 1975-02-28 1976-09-03 Chugai Pharmaceutical Co Ltd 1 arufua 255 jihidorokishikorekarushifuerooruno seiho
JPS5576858A (en) * 1978-12-04 1980-06-10 Teijin Ltd 24-fluoro-25-hydroxyvitamin d3 or its oh-protected derivative, and their preparation
JPS55111460A (en) * 1979-02-16 1980-08-28 Sachiko Yamada Novel vitamin d3 derivative and its preparation
JPS55111462A (en) * 1979-02-19 1980-08-28 Sachiko Yamada Novel vitamin d3 derivative and its preparation
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
US4201881A (en) * 1979-03-28 1980-05-06 Wisconsin Alumni Research Foundation 24,24-Difluoro-1α,25-dihydroxycholecalciferol

Also Published As

Publication number Publication date
EP0073465A3 (en) 1983-06-08
AU8779682A (en) 1983-03-03
IL66651A0 (en) 1982-12-31
DK154644C (en) 1989-05-01
DK154644B (en) 1988-12-05
JPS5852268A (en) 1983-03-28
DK386082A (en) 1983-03-01
CA1189537A (en) 1985-06-25
PH21625A (en) 1987-12-11
EP0073465B1 (en) 1986-02-05
ATE17848T1 (en) 1986-02-15
DE3268960D1 (en) 1986-03-20
EP0073465A2 (en) 1983-03-09
AU559509B2 (en) 1987-03-12
NZ201702A (en) 1985-08-16
IE53831B1 (en) 1989-03-15
IL66651A (en) 1986-03-31
IE822083L (en) 1983-02-28

Similar Documents

Publication Publication Date Title
DE3175042D1 (en) 7-oxo-4-thia-1-aza(3,2,0)heptane and 7-oxo-4-thia-1-aza(3,2,0)hept-2-ene derivatives
YU42637B (en) Process for preparing 1,8-naphthydrine compound
PT74188A (en) Process for the enzymatic preparation of l-2-amino-4-methyl- phosphinobutyric acid
DE3268960D1 (en) Cholecalciferol derivatives
PH17879A (en) Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-beta-congeners
DE2961985D1 (en) A process for the manufacture of substantially pure 3-amino-4-alkoxy-acylanilides from 2,4-dinitrochlorobenzene
DE3061059D1 (en) Carbinol ethers, process for their preparation and fungicides containing them
YU40718B (en) Process for obtaining new dibenzo|d,g/1.3.6¨dioxazocine derivatives
FR2393033A1 (en) PROCESS FOR PREPARING A BIS-AZOMETHINIC PIGMENT
DE3065467D1 (en) Processes for the production of 1,2,3-trihydroxyphenyl compounds
JPS55133325A (en) Manufacture of pentadienol
HUT33992A (en) Process for preparing 2,3,5,6-tetrasubstituted p- benzoquinones
AU565183B2 (en) 3-amino-1-phenoxy-2-propanol derivatives
EP0073451A3 (en) Carbapenam compound and processes for the preparation thereof
YU182879A (en) Process for obtaining a heterocyclic chemical compound, the 6-phenyl-(1,2,3)-oxadazolo(4,5-d)-pyridazin-7-(6h)-one
CU34997A (en) Procedure for the chemical compound production
JPS5253885A (en) Process for peparing a novel 7alpha-methoxycephalosporin derivative